EVAX

News US Stocks To Open Lower As Index Future Decline: Analysts Remain Upbeat About Santa Rally

14d ago

News Evaxion Biotech Partners With Merck To Expand Vaccine Development

14d ago

SEC filing EVAX to Present Preclinical EVX-04 AML Vaccine Data at EHA 2026 Congress

21d ago

SEC filing EVAX Reports $1.2B Revenue, $0.05 EPS, +150% YoY, Announces $200M Cancer Vaccine Trial, Cash to 2027

26d ago

SEC filing EVAX Reports $0 Revenue, -$0.08 EPS, Adopts $11.9M Warrant Authorization, $73.5M Convertible Loan Facility

41d ago

SEC filing EVAX Reports 86% Vaccine Target Precision, $12M Revenue, +94% YoY Growth, Phase 2 EVX-01 Trial Success

45d ago

SEC filing EVAX Reports $1.2B Revenue, $0.05 EPS, +150% YoY, Announces Glioblastoma Vaccine Breakthrough with ERV Antigens, AACR Presentation April 22

45d ago

SEC filing EVAX Reports $0 Revenue, $0 EPS, Reelects 4 Board Members, Elects 1 New Director

47d ago

SEC filing EVAX Announces Annual General Meeting April 16 2026 at 14.00 CET Copenhagen Denmark

75d ago

SEC filing EVAX Announces AGM 16 Apr 2026 14:00 CEST; Proposes Chairman Lars Lüthjohan; Recommends 2025 Report Adoption; Carries Forward Loss; Reelects Board Including New Member Jens Bitsch-Nørhave; Reelects EY Auditor; Seeks Warrant Authorization Up to DKK 11.9M

75d ago

SEC filing EVAX Presents Two AACR Abstracts: EVX-01 Biomarker Data, AI-Immunology™ Glioblastoma Strategy

76d ago

SEC filing EVAX Announces Business Update, Full Year 2025 Financial Results on March 5

92d ago

SEC filing EVAX Files Form 6-K for February 2026, No Financials Disclosed

94d ago

News Tactile Systems Stock Smashes 52-Week High After Strong Quarter

104d ago

News Stock Market Today: Dow Jones, S&P 500 Futures Jump Ahead Of January FOMC Minutes—Palo Alto Networks, Tactile Systems, DoorDash In Focus

104d ago

News Tactile Medical expects 8%-11% revenue growth in 2026 while expanding integrated lymphedema solutions

104d ago

News Vanguard ESG U.S. Corporate Bond ETF declares monthly distribution of $0.2501

123d ago

Scanner Unusual volume (2.8x average)

124d ago

News AstraZeneca To Delist ADRs From Nasdaq By January, Eyes Broader Investor Reach

132d ago

News Evaxion expands AI-Immunology™ platform into autoimmune diseases

140d ago

News Evaxion appoints Dr Helen Tayton-Martin as new Chief Executive Officer

153d ago

News Evaxion raises $7.2 million, extending cash runway to second half of 2027

153d ago

News Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares

155d ago

News Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out

155d ago

News Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out

164d ago